Search results

1. Mr Oscar Baldwin

   ... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...

2. Dr Saif Ahmad

   I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...

3. Dr Sujath Abbas

   ... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...

4. Professor Walid Khaled

   ... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...

5. Dr David Gilligan

   David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

6. Mr David Thurtle

   Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

7. Dr Roisin Owens

   Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

8. Mr Thierry Lefebvre

   Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

9. Mr Adam Palmer

10. Dr Avgi Andreou

11. Dr Alexander Azizi

12. Miss Ariella Stewart

13. Mrs Abigail Redman

14. Dr Anita Chandra

15. Dr Aideen Daly

16. Dr Andrea Degasperi

17. Miss Aristi Damaskou

18. Mr Alexander Evtushenko

19. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

20. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

21. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

22. Dr Alasdair Russell

    Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel...

23. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition NGS data analysis

24. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

25. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

26. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

27. Dr Alex Cagan

    My research seeks  to understand the somatic evolutionary processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an almost imperceptibly slow process. However, the cells that...

28. Dr Andre Neves

    As a chemical engineer, I enjoy translating basic science into novel biomedical technologies. I am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm...

29. Dr Adelyne Chan

    Biology of Ras-induced senescence

30. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what ...

31. Dr Adrien Hallou

    ... from statistical and soft matter physics with wet lab biology experiments to understand the role of cellular heterogeneity in cell ...

32. Dr Tony Jackson

    Proteomic approaches to plasma-membrane assemblies: Membrane proteins cluster together selectively as spatially-restricted, functionally integrated complexes. This can play an important role in many biological processes, including signal transduction....

33. Dr Adrian Kelly

    Biology of MHC class I and class II antigen processing and presentation pathways.

34. Professor Tony Green

    ... pathway has essential roles in several aspects of metazoan biology including haematopoiesis and stem cell function. Somatic mutations ...

35. Dr Arnaud Comment

    ... by MR imaging, a recent discipline combining molecular biology and in vivo imaging, aims at differentiating tissues based upon their ...

36. Dr Alex Samoshkin

    ... cancer research (NICHD and NCI, NIH, USA) and neuroscience biology (UNC, Chapel Hill, USA). ...

37. Dr Athena Matakidou

    ... will allow in-vivo investigations of the underlying tumour biology and the discovery of new methodologies for the detection, management ...

38. Dr Ian McGough

    ... to promote further tumour growth and metastasis. Such a scenario occurs in prostate cancer, in which tumour cells ...

39. Dr Jane Dobson

    ... area of interest is in strategies for prevention of metastasis. My principle research interest is in soft tissue sarcomas, and the ...

40. Dr Lucy Yates

    ... heterogeneity and the evolutionary patterns underlying metastasis. My current work draws on novel genomic technologies such as in-situ ...

41. Professor Matthew Allen

    My laboratory is interested in preclinical modelling of musculoskeletal cancer, with a particular emphasis on paediatric cancers (such as osteosarcoma, rhabdomyosarcoma and Ewings sarcoma) and adult cancers that spread to bone (such as breast, prostate,...

42. Dr Helen Mott

    ... family, such as Cdc42 and Rac are important for invasion and metastasis. We are using a combination of structural biology and biochemical ...

43. Dr Robert Kay

    ... and PI4P5kinase in chemotaxis. Relation of model to metastasis. Also the fundamental role of human disease proteins: ...

44. Professor Randall Johnson

    We work on how the body responds to hypoxia, or low levels of tissue oxygen.  This is relevant to a number of diseases, including cancer, and the laboratory is interested in hypoxic response in disease as well as in normal physiology. The response to...

45. Dr Sakari Vanharanta

    ... spread of cancer to secondary organs in a phenomenon called metastasis. Recent advances have shown that systematic experimental approaches can identify key molecular drivers of metastasis. Still, in most cases metastatic cancer remains incurable. The vast ...

Pages